THE COSTS OF TREATING BREAST CANCER IN AUSTRALIA AND THE IMPLICATIONS FOR BREAST CANCER SCREENING

Australian and New Zealand Journal of Surgery - Tập 65 Số 7 - Trang 485-491 - 1995
James R. G. Butler1, Colin Furnival2, Ruth F.G. Hart3
1National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia
2†Division of Surgery, The Royal Brisbane Hospital, Brisbane, Queensland, Australia
3Department of Applied Economics, Victoria University of Technology, Melbourne, Victoria, Australia

Tóm tắt

The aim of the study was to determine if there is a relationship between the stage of breast cancer at the time of detection and the costs of treatment and to assess whether any such relationship would have an influence on the cost of a mammographic screening programme.A retrospective analysis of the stage at presentation for primary breast cancer and the treatment costs over the duration of treatment was made. Multiple regression analysis was employed, with treatment cost as the dependent variable and categorical variables to represent stage at detection. A total of 301 women whose treatment for breast cancer commenced at the Royal Brisbane Hospital participated in the study.A statistically signficiant relationship was found between the stage of disease at the time of detection and subsequent treatment costs; more advanced stages of disease incurred higher treatment costs. This relationship was robust even after taking into account the age of patients, their discharge status, and differences between patients in the duration of treatment. When the effect of earlier detection on treatment cost was assessed in relation to a breast screening programme, cost savings were estimated to be in the range of 8–36% of total screening costs.There are treatment cost savings to be gained from breast cancer screening as a result of the detection of earlier stages of disease. These treatment cost savings should be offset against the cost of a mammographic screening programme.

Từ khóa


Tài liệu tham khảo

10.1001/jama.1971.03180240027005

Roberts MM, 1990, Edinburgh Trial of screening for early breast cancer: Mortality at seven years, Lancet, 241

10.1002/bjs.1800680413

GoddurdM. HuttonJ.The costs of radiotherapy in cancer treatment. University of York. Centre for Health Economics1988. Discussion Paper No. 58.

10.1038/bjc.1992.91

10.1093/jnci/85.18.1460

Drummond MF, 1987, Methods for the Economic Evaluation of Health Care, Programs

10.1007/978-3-642-82982-6

Union Internationale Centre Cancer., 1973, TNM Classification of Malignant Tumours

Butler JRG, 1995, Estimating treatment cost functions for progressive diseases: A multi‐product approach with an application to breast cancer, J. Health Economics, 3

GilesGG AmistrongBK SmithLR.Cancer in Australia1982.National Statistics Clearing House. Scientific Publication No. I; Australian Institute of Health. Canberra. 1987.

Eddy DM, 1988, The value of mammography screening in women under age 50 years, JAMA, 10, 1512, 10.1001/jama.1988.03720100030034

Dillon WR, 1984, Multivariate Analysis

Report from the Yorkshire Breast Cancer Group., 1977, Observer variation in recording clinical data from women presenting with breast lesions, BMJ, 1196

Donegan WL, 1988, Cancer of the, Breast, 46

10.1136/bmj.297.6654.943

10.5694/j.1326-5377.1990.tb125305.x

Australian Health Ministers' Advisory Council, 1990, Australian Institute of Health Prevention Program Evaluation

Thông tin
Thông tin xuất bản

Australian and New Zealand Journal of Surgery

Tập 65 Số 7

485-491

Thông tin tác giả